126 related articles for article (PubMed ID: 20590388)
21. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
22. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.
Zhou L; Rui JA; Ye DX; Wang SB; Chen SG; Qu Q
World J Surg; 2008 Aug; 32(8):1748-56. PubMed ID: 18493820
[TBL] [Abstract][Full Text] [Related]
23. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
24. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.
Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.
Shen SQ; Li K; Zhu N; Nakao A
Med Oncol; 2008; 25(3):341-5. PubMed ID: 18214716
[TBL] [Abstract][Full Text] [Related]
26. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
[TBL] [Abstract][Full Text] [Related]
28. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of caprin1 expression is associated with poor prognosis in hepatocellular carcinoma.
Tan N; Dai L; Liu X; Pan G; Chen H; Huang J; Xu Q
Pathol Res Pract; 2017 Dec; 213(12):1563-1567. PubMed ID: 29037839
[TBL] [Abstract][Full Text] [Related]
30. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
31. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
32. Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma.
Zhang Y; Deng ZS; Liao MM; Wang N; Zhang XQ; Yu HY; Zhang YD
Pathol Oncol Res; 2012 Oct; 18(4):911-6. PubMed ID: 22434316
[TBL] [Abstract][Full Text] [Related]
33. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract][Full Text] [Related]
34. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.
Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X
Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723
[TBL] [Abstract][Full Text] [Related]
35. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jung HI; Jeong D; Ji S; Ahn TS; Bae SH; Chin S; Chung JC; Kim HC; Lee MS; Baek MJ
Cancer Res Treat; 2017 Jan; 49(1):246-254. PubMed ID: 27456947
[TBL] [Abstract][Full Text] [Related]
37. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
[TBL] [Abstract][Full Text] [Related]
38. [Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy].
Zhao J; Yan T; Bi X; Zhao H; Huang Z; Zhou J; Li Z; Li C; Cai J
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):430-4. PubMed ID: 25241784
[TBL] [Abstract][Full Text] [Related]
39. Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.
Zhu X; Qi G; Li C; Bei C; Tan C; Zhang Y; Shi W; Zeng W; Kong J; Fu Y; Tan S
DNA Cell Biol; 2019 Feb; 38(2):193-197. PubMed ID: 30562063
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
